| 000 | 01197 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517153123.0 | ||
| 264 | 0 | _c20180425 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.17254 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChoi, Jung-Suk | |
| 245 | 0 | 0 |
_aInhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents. _h[electronic resource] |
| 260 |
_bOncotarget _cJun 2017 |
||
| 300 |
_a40804-40816 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 | _aDNA Replication |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xbiosynthesis |
| 650 | 0 | 4 |
_aDNA-Directed DNA Polymerase _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 700 | 1 | _aKim, Seol | |
| 700 | 1 | _aMotea, Edward | |
| 700 | 1 | _aBerdis, Anthony | |
| 773 | 0 |
_tOncotarget _gvol. 8 _gno. 25 _gp. 40804-40816 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.17254 _zAvailable from publisher's website |
| 999 |
_c27159014 _d27159014 |
||